BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Horowitz JM, Kamel IR, Arif-tiwari H, Asrani SK, Hindman NM, Kaur H, Mcnamara MM, Noto RB, Qayyum A, Lalani T. ACR Appropriateness Criteria ® Chronic Liver Disease. Journal of the American College of Radiology 2017;14:S391-405. [DOI: 10.1016/j.jacr.2017.08.045] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Haj-mirzaian A, Kadivar A, Kamel IR, Zaheer A. Updates on Imaging of Liver Tumors. Curr Oncol Rep 2020;22. [DOI: 10.1007/s11912-020-00907-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
2 Morin CE, Dillman JR, Serai SD, Trout AT, Tkach JA, Wang H. Comparison of Standard Breath-Held, Free-Breathing, and Compressed Sensing 2D Gradient-Recalled Echo MR Elastography Techniques for Evaluating Liver Stiffness. American Journal of Roentgenology 2018;211:W279-87. [DOI: 10.2214/ajr.18.19761] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
3 Eisenbrey JR, Gabriel H, Savsani E, Lyshchik A. Contrast-enhanced ultrasound (CEUS) in HCC diagnosis and assessment of tumor response to locoregional therapies. Abdom Radiol (NY) 2021;46:3579-95. [PMID: 33825927 DOI: 10.1007/s00261-021-03059-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
4 Schleiger A, Salzmann M, Kramer P, Danne F, Schubert S, Bassir C, Müller T, Müller HP, Berger F, Ovroutski S. Severity of Fontan-Associated Liver Disease Correlates with Fontan Hemodynamics. Pediatr Cardiol 2020;41:736-46. [PMID: 32006084 DOI: 10.1007/s00246-020-02291-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
5 Petrasek J, Singal AG, Rich NE. Harms of hepatocellular carcinoma surveillance. Curr Hepatol Rep 2019;18:383-9. [PMID: 33214987 DOI: 10.1007/s11901-019-00488-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Arani A, Manduca A, Ehman RL, Huston Iii J. Harnessing brain waves: a review of brain magnetic resonance elastography for clinicians and scientists entering the field. Br J Radiol 2021;94:20200265. [PMID: 33605783 DOI: 10.1259/bjr.20200265] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Nandwana SB, Finazzo J, Alexander LF, Cox K. Using qualitative descriptors of chronic liver disease on MRI: A practice prone to error. Clin Imaging 2021;74:89-92. [PMID: 33461018 DOI: 10.1016/j.clinimag.2020.12.023] [Reference Citation Analysis]
8 Pinchot JW, Kalva SP, Majdalany BS, Kim CY, Ahmed O, Asrani SK, Cash BD, Eldrup-Jorgensen J, Kendi AT, Scheidt MJ, Sella DM, Dill KE, Hohenwalter EJ; Expert Panels on Interventional Radiology and Vascular Imaging. ACR Appropriateness Criteria® Radiologic Management of Portal Hypertension. J Am Coll Radiol 2021;18:S153-73. [PMID: 33958110 DOI: 10.1016/j.jacr.2021.02.013] [Reference Citation Analysis]
9 Powell AC, Wang Y, Smith GL, Long JW, Deshmukh UU, Friedman DP, Roth CG, Sundaram B. Outpatient facility-based order variation in combined imaging. PLoS One 2019;14:e0224735. [PMID: 31725755 DOI: 10.1371/journal.pone.0224735] [Reference Citation Analysis]
10 Wang J, Yang L, Diao Y, Liu J, Li J, Li R, Zheng L, Zhang K, Ma Y, Hao X. Circulating tumour DNA methylation in hepatocellular carcinoma diagnosis using digital droplet PCR. J Int Med Res 2021;49:300060521992962. [PMID: 33750234 DOI: 10.1177/0300060521992962] [Reference Citation Analysis]
11 Chernyak V, Horowitz JM, Kamel IR, Arif-tiwari H, Bashir MR, Cash BD, Farrell J, Goldstein A, Grajo JR, Gupta S, Hindman NM, Kamaya A, Mcnamara MM, Porter KK, Solnes LB, Srivastava PK, Zaheer A, Carucci LR. ACR Appropriateness Criteria® Liver Lesion-Initial Characterization. Journal of the American College of Radiology 2020;17:S429-46. [DOI: 10.1016/j.jacr.2020.09.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Zhang Y, Numata K, Du Y, Maeda S. Contrast Agents for Hepatocellular Carcinoma Imaging: Value and Progression. Front Oncol 2022;12:921667. [PMID: 35720001 DOI: 10.3389/fonc.2022.921667] [Reference Citation Analysis]
13 Hindman NM, Arif-Tiwari H, Kamel IR, Al-Refaie WB, Bartel TB, Cash BD, Chernyak V, Goldstein A, Grajo JR, Horowitz JM, Kamaya A, McNamara MM, Porter KK, Srivastava PK, Zaheer A, Carucci LR; Expert Panel on Gastrointestinal Imaging:. ACR Appropriateness Criteria® Jaundice. J Am Coll Radiol 2019;16:S126-40. [PMID: 31054739 DOI: 10.1016/j.jacr.2019.02.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
14 Cooper GS. Should We Abandon Current Hepatocellular Carcinoma Screening Practices? Gastroenterology 2018;155:972-4. [DOI: 10.1053/j.gastro.2018.09.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]